|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-1-12
|
|
pubmed:abstractText |
BCL6 gene rearrangement is the most frequent chromosomal abnormality in diffuse large B-cell lymphoma, a malignancy characterized by genetic heterogeneity and wide variability in clinical outcome. The prognostic significance of BCL6 rearrangement has not been evaluated in the context of rituximab therapy for diffuse large B-cell lymphoma. We analyzed the effect of the BCL6 rearrangement on survival in patients with diffuse large B-cell lymphoma treated with CHOP and CHOP plus rituximab (R-CHOP).
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-10676951,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-11023530,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-11493437,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-11926184,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-11972514,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-12515714,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-12576316,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-14504078,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-15867204,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-16418498,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-16449523,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-16760442,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-17105812,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-17625604,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-18494613,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-18754028,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-19038878,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-8141877,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-8167331,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-8208268,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-8220427,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-8235596,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-9541684,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797725-9787151
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal...,
http://linkedlifedata.com/resource/pubmed/chemical/BCL6 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Prednisone,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/Vincristine,
http://linkedlifedata.com/resource/pubmed/chemical/rituximab
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1592-8721
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
95
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
96-101
|
|
pubmed:meshHeading |
pubmed-meshheading:19797725-Adolescent,
pubmed-meshheading:19797725-Adult,
pubmed-meshheading:19797725-Aged,
pubmed-meshheading:19797725-Aged, 80 and over,
pubmed-meshheading:19797725-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:19797725-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19797725-Cohort Studies,
pubmed-meshheading:19797725-Cyclophosphamide,
pubmed-meshheading:19797725-DNA-Binding Proteins,
pubmed-meshheading:19797725-Doxorubicin,
pubmed-meshheading:19797725-Female,
pubmed-meshheading:19797725-Follow-Up Studies,
pubmed-meshheading:19797725-Gene Rearrangement, B-Lymphocyte,
pubmed-meshheading:19797725-Humans,
pubmed-meshheading:19797725-Immunophenotyping,
pubmed-meshheading:19797725-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:19797725-Male,
pubmed-meshheading:19797725-Middle Aged,
pubmed-meshheading:19797725-Prednisone,
pubmed-meshheading:19797725-Retrospective Studies,
pubmed-meshheading:19797725-Survival Rate,
pubmed-meshheading:19797725-Treatment Outcome,
pubmed-meshheading:19797725-Tumor Markers, Biological,
pubmed-meshheading:19797725-Vincristine,
pubmed-meshheading:19797725-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP.
|
|
pubmed:affiliation |
Division of Medical Oncology, Laboratory Medicine, BC Cancer Agency, University of British Columbia, Vancouver, Canada.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
